# Pharmacokinetics Profiles of HQP1351 Under Fasting and High-fat Meals in Patients With Chronic Myeloid Leukemia

> **NCT03882281** · PHASE1 · COMPLETED · sponsor: **Ascentage Pharma Group Inc.** · enrollment: 12 (actual)

## Conditions studied

- Chronic Myeloid Leukemia, Chronic Phase

## Interventions

- **DRUG:** HQP1351

## Key facts

- **NCT ID:** NCT03882281
- **Lead sponsor:** Ascentage Pharma Group Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-25
- **Primary completion:** 2019-11-16
- **Final completion:** 2019-11-16
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2020-01-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03882281

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03882281, "Pharmacokinetics Profiles of HQP1351 Under Fasting and High-fat Meals in Patients With Chronic Myeloid Leukemia". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03882281. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*